HIV

Gilead Sciences Demonstrates Commitment to Scientific Innovation In HIV With New Prevention, Treatment and Cure Research Data Presented At AIDS 2020: Virtual

By
1 Mins read
134
0
Share
Reading Time: < 1 minute

Gilead Sciences, Inc. (Nasdaq:GILD) today announced that new data from the company’s HIV research and development program will be presented at the 23rd International AIDS Conference Read More

134
0
Share
Related posts
HIV

Sir Elton John tackles Trump administration cuts with $1,000,000 health plan

By
1 Mins read
Reading Time: < 1 minute Sir Elton John isn’t done collaborating with Brandi Carlile yet as the pair join forces to offset cuts to HIV and AIDS funding by US President Donald Trump.  Read…
HIV

NACA assures Nigerians of steady supply of HIV drugs

By
1 Mins read
Reading Time: < 1 minute The National Agency for the Control of AIDS on Wednesday reassured Nigerians, particularly those living with HIV, that the country has a…
HIV

‘It’s back to drug rationing’: the end of HIV was in sight. Then came the cuts

By
1 Mins read
Reading Time: < 1 minute This year the world should have been “talking about the virtual elimination of HIV” in the near future.
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.